Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chin-Yang Li

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Cancer|March 15, 2006
Respective clustering of unfavorable and favorable cytogenetic clones in myelofibrosis with myeloid metaplasia with homozygosity for JAK2(V617F) and response to erythropoietin therapyAyalew Tefferi, Jacob J Strand, Terra L Lasho, et al.
International Journal of Clinical and Experimental Pathology|February 18, 2011
Hairy cell leukemia and variant in Taiwan: report of a variant case and literature reviewYen-Chuan Hsieh, Shen-Tsung Chang, Shih-Sung Chuang, et al.
British Journal of Haematology|October 18, 2005
The JAK2(V617F) tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlatesAyalew Tefferi, Terra L Lasho, Susan M Schwager, et al.
European Journal of Haematology|December 18, 2007
Cytogenetic studies at diagnosis in polycythemia vera: clinical and JAK2V617F allele burden correlatesNaseema Gangat, Jacob Strand, Terra L Lasho, et al.
Blood|April 14, 2009
Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factorsKen-Hong Lim, Ayalew Tefferi, Terra L Lasho, et al.
Blood|July 24, 2010
Lenalidomide and prednisone for myelofibrosis: Eastern Cooperative Oncology Group (ECOG) phase 2 trial E4903Ruben A Mesa, Xiaopan Yao, Larry D Cripe, et al.
British Journal of Haematology|April 26, 2002
Thalidomide treatment in myelofibrosis with myeloid metaplasiaMichelle A Elliott, Ruben A Mesa, Chin-Yang Li, et al.
European Journal of Haematology|January 29, 2008
20+ yr without leukemic or fibrotic transformation in essential thrombocythemia or polycythemia vera: predictors at diagnosisAyalew Tefferi, Naseema Gangat, Alexandra P Wolanskyj, et al.
Blood|December 31, 2002
Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disordersAnimesh Pardanani, Terra Reeder, Luis F Porrata, et al.
British Journal of Haematology|October 4, 2005
Concomitant neutrophil JAK2 mutation screening and PRV-1 expression analysis in myeloproliferative disorders and secondary polycythaemiaAyalew Tefferi, Shireen Sirhan, Terra L Lasho, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Cancer|March 15, 2006
Respective clustering of unfavorable and favorable cytogenetic clones in myelofibrosis with myeloid metaplasia with homozygosity for JAK2(V617F) and response to erythropoietin therapyAyalew Tefferi, Jacob J Strand, Terra L Lasho, et al.
International Journal of Clinical and Experimental Pathology|February 18, 2011
Hairy cell leukemia and variant in Taiwan: report of a variant case and literature reviewYen-Chuan Hsieh, Shen-Tsung Chang, Shih-Sung Chuang, et al.
British Journal of Haematology|October 18, 2005
The JAK2(V617F) tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlatesAyalew Tefferi, Terra L Lasho, Susan M Schwager, et al.
European Journal of Haematology|December 18, 2007
Cytogenetic studies at diagnosis in polycythemia vera: clinical and JAK2V617F allele burden correlatesNaseema Gangat, Jacob Strand, Terra L Lasho, et al.
Blood|April 14, 2009
Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factorsKen-Hong Lim, Ayalew Tefferi, Terra L Lasho, et al.
Blood|July 24, 2010
Lenalidomide and prednisone for myelofibrosis: Eastern Cooperative Oncology Group (ECOG) phase 2 trial E4903Ruben A Mesa, Xiaopan Yao, Larry D Cripe, et al.
British Journal of Haematology|April 26, 2002
Thalidomide treatment in myelofibrosis with myeloid metaplasiaMichelle A Elliott, Ruben A Mesa, Chin-Yang Li, et al.
European Journal of Haematology|January 29, 2008
20+ yr without leukemic or fibrotic transformation in essential thrombocythemia or polycythemia vera: predictors at diagnosisAyalew Tefferi, Naseema Gangat, Alexandra P Wolanskyj, et al.
Blood|December 31, 2002
Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disordersAnimesh Pardanani, Terra Reeder, Luis F Porrata, et al.
British Journal of Haematology|October 4, 2005
Concomitant neutrophil JAK2 mutation screening and PRV-1 expression analysis in myeloproliferative disorders and secondary polycythaemiaAyalew Tefferi, Shireen Sirhan, Terra L Lasho, et al.
Pageof 6